193 related articles for article (PubMed ID: 23867089)
1. Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO.
Rydevik A; Bondesson U; Thevis M; Hedeland M
J Pharm Biomed Anal; 2013 Oct; 84():278-84. PubMed ID: 23867089
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a β-glucuronide of hydroxylated SARM S1 produced using a combination of biotransformation and chemical oxidation.
Rydevik A; Lagojda A; Thevis M; Bondesson U; Hedeland M
J Pharm Biomed Anal; 2014 Sep; 98():36-9. PubMed ID: 24879518
[TBL] [Abstract][Full Text] [Related]
3. A novel trapping system for the detection of reactive drug metabolites using the fungus Cunninghamella elegans and high resolution mass spectrometry.
Rydevik A; Hansson A; Hellqvist A; Bondesson U; Hedeland M
Drug Test Anal; 2015 Jul; 7(7):626-33. PubMed ID: 25209992
[TBL] [Abstract][Full Text] [Related]
4. The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs).
Rydevik A; Thevis M; Krug O; Bondesson U; Hedeland M
Xenobiotica; 2013 May; 43(5):409-20. PubMed ID: 23153056
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.
Wen Z; Stern ST; Martin DE; Lee KH; Smith PC
Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262
[TBL] [Abstract][Full Text] [Related]
6. Acyl glucuronidation and glucosidation of a new and selective endothelin ET(A) receptor antagonist in human liver microsomes.
Tang C; Hochman JH; Ma B; Subramanian R; Vyas KP
Drug Metab Dispos; 2003 Jan; 31(1):37-45. PubMed ID: 12485951
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.
Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265
[TBL] [Abstract][Full Text] [Related]
8. Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.
Shipkova M; Armstrong VW; Wieland E; Niedmann PD; Schütz E; Brenner-Weiss G; Voihsel M; Braun F; Oellerich M
Br J Pharmacol; 1999 Mar; 126(5):1075-82. PubMed ID: 10204993
[TBL] [Abstract][Full Text] [Related]
9. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes.
Kuuranne T; Leinonen A; Schänzer W; Kamber M; Kostiainen R; Thevis M
Drug Metab Dispos; 2008 Mar; 36(3):571-81. PubMed ID: 18086831
[TBL] [Abstract][Full Text] [Related]
10. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism study of a black market product containing SARM LGD-4033.
Geldof L; Pozo OJ; Lootens L; Morthier W; Van Eenoo P; Deventer K
Drug Test Anal; 2017 Feb; 9(2):168-178. PubMed ID: 26767942
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroids.
Jäntti SE; Kiriazis A; Reinilä RR; Kostiainen RK; Ketola RA
Steroids; 2007 Mar; 72(3):287-96. PubMed ID: 17250861
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite.
Aprile S; Del Grosso E; Grosa G
Xenobiotica; 2009 Feb; 39(2):148-61. PubMed ID: 19255941
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
[TBL] [Abstract][Full Text] [Related]
16. Route of metabolization and detoxication of paralytic shellfish toxins in humans.
García C; Barriga A; Díaz JC; Lagos M; Lagos N
Toxicon; 2010 Jan; 55(1):135-44. PubMed ID: 19632259
[TBL] [Abstract][Full Text] [Related]
17. Preparation of glucuronides using liver microsomes and their characterization by 1D/2D NMR spectroscopy and mass spectrometry: Application to fentanyl metabolites.
Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
Drug Test Anal; 2024 May; 16(5):447-456. PubMed ID: 37583076
[TBL] [Abstract][Full Text] [Related]
18. Enhanced screening of glutathione-trapped reactive metabolites by in-source collision-induced dissociation and extraction of product ion using UHPLC-high resolution mass spectrometry.
Zhu X; Kalyanaraman N; Subramanian R
Anal Chem; 2011 Dec; 83(24):9516-23. PubMed ID: 22077671
[TBL] [Abstract][Full Text] [Related]
19. Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.
Darnell M; Breitholtz K; Isin EM; Jurva U; Weidolf L
Chem Res Toxicol; 2015 May; 28(5):886-96. PubMed ID: 25803559
[TBL] [Abstract][Full Text] [Related]
20. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite.
Schwartz MS; Desai RB; Bi S; Miller AR; Matuszewski BK
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):116-24. PubMed ID: 16716772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
